0114 GMT - AMMB Holdings' canceling the sale of its life insurance unit to Great Eastern comes as no surprise, given the prolonged delay, Maybank IB analyst Desmond Ch'ng says in a note. He notes that there has been no progress on the deal since it was first proposed in October 2023. The impact on AMMB's capital is minimal, with its Common Equity Tier 1 ratio at a solid 15.3%, he reckons. While a sale may still be considered, there is no urgency, he adds. Ch'ng expects AMMB to see 11.7% earnings growth in FY 2025, supported by better net interest margins and lower credit costs. Maybank maintains a buy rating on AMMB and keeps the target price at MYR6.30. Shares are 0.2% higher at MYR5.65. (yingxian.wong@wsj.com)
(END) Dow Jones Newswires
February 03, 2025 20:14 ET (01:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.